0.0700
0.0000
(0.00%)
At close: April 8 at 4:10:10 PM GMT+10
Key Executives
Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in AUD.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Ms. Narelle Warren B.Com, B.Com., L.L.B., LLB | CFO & Company Secretary | 244.25k | -- | -- |
| Dr. Thomas Duthy M.B.A., Ph.D. | Executive Director | 339.58k | -- | -- |
Invex Therapeutics Ltd
38 Rowland Street
Level 2 Subiaco
Perth, WA 6008
Australia
- Sector:
- Healthcare
- Industry: Biotechnology
Description
Invex Therapeutics Ltd, a biopharmaceutical company, engages in the research and development of treatments for neurological conditions in Australia. It is involved in developing Exenatide, a treatment for neurological conditions derived from or involving raised intracranial pressure, such as idiopathic intracranial hypertension, acute stroke, and traumatic brain injury that has completed Phase III clinical trial. The company was incorporated in 2019 and is based in Perth, Australia.
Corporate Governance
Invex Therapeutics Ltd’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
February 6, 2025 at 10:30 PM UTC
Invex Therapeutics Ltd Earnings Date
Recent Events
December 8, 2023 at 12:00 AM UTC
Ex-Dividend Date
Related Tickers
NSB.AX NeuroScientific Biopharmaceuticals Limited
0.0350
0.00%
BTC.AX BTC Health Limited
0.0460
-8.00%
VBS.AX Vectus Biosystems Limited
0.0800
0.00%
ANR.AX Anatara Lifesciences Ltd
0.0060
0.00%
RNV.AX RENERVE FPO [RNV]
0.1100
+4.76%
1AI.AX Algorae Pharmaceuticals Limited
0.0060
+20.00%
TRP.AX Tissue Repair Ltd
0.2400
0.00%
BGT.AX Bio-Gene Technology Limited
0.0310
0.00%
CMB.AX Cambium Bio Limited
0.3000
+7.14%
ATX.AX Amplia Therapeutics Limited
0.0520
-1.89%